Company Overview of Lapid Pharmaceuticals Ltd.
Lapid Pharmaceuticals, Ltd. develops orally ingested drugs. Its products include drugs based on doxorubicin for treatment of hard tumors; GnRH for prostate cancer; and metenkephalin, a naturally occurring pain reliever. Lapid Pharmaceuticals, Ltd. was founded in 1998 and is based in Rehovot, Israel.
Weizmann Inst. Campus
Founded in 1998
Key Executives for Lapid Pharmaceuticals Ltd.
Similar Private Companies By Industry
|Abital Pharma Pipelines Ltd.||Middle East/Africa|
|Active PX Ltd.||Middle East/Africa|
|Advanced Inhalation Technology Ltd.||Middle East/Africa|
|Alvit LCS Pharma Ltd||Middle East/Africa|
|Angio B Ltd.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Lapid Pharmaceuticals Ltd., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.